Abstract:Postoperative ileus (POI) and postoperative gastrointestinal tract dysfunction (POGD) are well-known complications affecting patients undergoing intestinal surgery. GI symptoms include nausea, vomiting, pain, abdominal distention, bloating, and constipation. These iatrogenic disorders are associated with extended hospitalizations, increased morbidity, and health care costs into the billions and current therapeutic strategies are limited. This is a narrative review focused on recent concepts in the pathogenesis of POI and POGD, pipeline drugs or approaches to treatment. Mechanisms, cellular targets and pathways implicated in the pathogenesis include gut surgical manipulation and surgical trauma, neuroinflammation, reactive enteric glia, macrophages, mast cells, monocytes, neutrophils and ICC’s. The precise interactions between immune, inflammatory, neural and glial cells are not well understood. Reactive enteric glial cells are an emerging therapeutic target that is under intense investigation for enteric neuropathies, GI dysmotility and POI. Our review emphasizes current therapeutic strategies, starting with the implementation of colorectal enhanced recovery after surgery protocols to protect against POI and POGD. However, despite colorectal enhanced recovery after surgery, it remains a significant medical problem and burden on the healthcare system. Over 100 pipeline drugs or treatments are listed in Clin.Trials.gov . These include 5HT 4 R agonists (Prucalopride and TAK 954), vagus nerve stimulation of the ENS—macrophage nAChR cholinergic pathway, acupuncture, herbal medications, peripheral acting opioid antagonists (Alvimopen, Methlnaltexone, Naldemedine), anti-bloating/flatulence drugs (Simethiocone), a ghreline prokinetic agonist (Ulimovelin), drinking coffee, and nicotine chewing gum. A better understanding of the pathogenic mechanisms for short and long-term outcomes is necessary before we can develop better prophylactic and treatment strategies.

Progress in Study on Mechanism and Management of Postoperative Ileus Caused by Morphine

Molecular mechanisms of postoperative ileus following gastrointestinal surgery

[Effect of Morphine Chloride on Contractility of Small Intestinal Muscle in Vitro or in Vivo and Its Mechanisms].

Molecular and Cellular Mechanisms Underlying Postoperative Paralytic Ileus by Various Immune Cell Types

[Advances in the Prevention and Treatment of Postoperative Ileus].

An outline of the management and prevention of postoperative ileus: A review

Opioid-induced Hyperalgesia in Chronic Pain Management

Postoperative ileus—Immune mechanisms and potential therapeutic interventions

Pathophysiology and Management of Postoperative Ileus in Adults and Neonates: A Review

Postoperative Ileus Murine Model

Multimodal Inhibition of Return Effects in Adults With and Without Down Syndrome

Postoperative Ileus and Postoperative Gastrointestinal Tract Dysfunction: Pathogenic Mechanisms and Novel Treatment Strategies Beyond Colorectal Enhanced Recovery After Surgery Protocols

Aspirin and Platelet Adenosine Diphosphate Receptor Antagonists in Acute Coronary Syndromes and Percutaneous Coronary Intervention

Postoperative Ileus after Minimally Invasive Colorectal Surgery: A Summary of Current Strategies for Prevention and Management

μ-Opioid Receptor–Mediated Enteric Glial Activation Is Involved in Morphine-Induced Constipation

From dysmotility to virulent pathogens: implications of opioid use in the ICU

Inflammation and Impaired Gut Physiology in Post-operative Ileus: Mechanisms and the Treatment Options

Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model

Total Postoperative Opioid Dose is an Independent Risk Factor for Prolonged Postoperative Ileus after Laparoscopic Colorectal Surgery: a Case-Control Study.

Can nerve impulse periodicity be used for pitch perception? In: Sensorineural hearing loss.

Post-operative ileus: definitions, mechanisms and controversies